SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
2019 · Nature Communications · 182 citations
https://doi.org/10.1038/s41467-019-08380-1
S
Sungmi Jung
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.2K
Citations
13
h-index
14
i10-index
Sungmi Jung is an academic researcher from McGill University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Bone Tumor Diagnosis and Treatments & Cancer Genomics and Diagnostics. The author has an h-index of 13, co-authored 37 publications.
ORCID: 0000-0002-9950-1387Papers by this author
worksSMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
2021 · Nature Communications · 67 citations
https://doi.org/10.1038/s41467-021-25260-9
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
2025 · Cancer Cell · 2 citations
https://doi.org/10.1016/j.ccell.2025.03.014
Two Cases of Polyethylene Granuloma After Distal Femoral Endoprosthesis With All-Polyethylene Tibia
2021 · Arthroplasty Today · 1 citations
https://doi.org/10.1016/j.artd.2020.12.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat